OXSR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.844200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.309200E-01
Normal-vs-Stage2
5.676600E-01
Normal-vs-Stage3
1.116200E-01
Normal-vs-Stage4
8.627600E-02
Stage1-vs-Stage2
1.910030E-01
Stage1-vs-Stage3
1.836850E-01
Stage1-vs-Stage4
1.740010E-02
Stage2-vs-Stage3
3.078200E-02
Stage2-vs-Stage4
1.153570E-01
Stage3-vs-Stage4
7.675500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.809000E-01
Normal-vs-AfricanAmerican
9.843400E-01
Normal-vs-Asian
8.982800E-01
Caucasian-vs-AfricanAmerican
5.460000E-01
Caucasian-vs-Asian
6.053800E-01
AfricanAmerican-vs-Asian
8.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.506600E-01
Normal-vs-Female
7.376200E-01
Male-vs-Female
5.497600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.643400E-01
Normal-vs-Age(41-60Yrs)
3.728800E-01
Normal-vs-Age(61-80Yrs)
8.431400E-01
Normal-vs-Age(81-100Yrs)
8.071600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.982600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.396200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.910200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.703800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.881800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.974800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.027200E-01
Normal-vs-Daily Drinker
9.623800E-01
Normal-vs-Weekly Drinker
8.585800E-01
Normal-vs-Occasional Drinker
2.701000E-01
Normal-vs-Social Drinker
6.113600E-01
Non Drinker-vs-Daily Drinker
8.555400E-01
Non Drinker-vs-Weekly Drinker
9.524000E-01
Non Drinker-vs-Occasional Drinker
7.892100E-02
Non Drinker-vs-Social Drinker
5.902800E-01
Daily Drinker-vs-Weekly Drinker
8.173400E-01
Daily Drinker-vs-Occasional Drinker
4.584100E-02
Daily Drinker-vs-Social Drinker
4.477800E-01
Weekly Drinker-vs-Occasional Drinker
1.132210E-01
Weekly Drinker-vs-Social Drinker
6.346000E-01
Occasional Drinker-vs-Social Drinker
2.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.651390E-01
Normal-vs-Grade 2
1.551850E-02
Normal-vs-Grade 3
2.443600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.249700E-04
Grade 1-vs-Grade 3
1.173880E-04
Grade 1-vs-Grade 4
1.651390E-01
Grade 2-vs-Grade 3
8.523600E-02
Grade 2-vs-Grade 4
1.551850E-02
Grade 3-vs-Grade 4
2.443600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.556200E-01
Normal-vs-NonDiabetic
7.066000E-01
Diabetic-vs-NonDiabetic
5.560600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.479000E-01
Normal-vs-NoPancreatitis
7.497600E-01
Pancreatitis-vs-NoPancreatitis
8.392200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.128200E-01
Normal-vs-N1
5.928000E-01
N0-vs-N1
3.089600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.569600E-01
Normal-vs-TP53-NonMutant
5.762200E-01
TP53-Mutant-vs-TP53-NonMutant
1.81771999999691E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
